Publication:
Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies

dc.contributor.authorBoonyarit Cheunsuchonen_US
dc.contributor.authorPimpattana Rungkaewen_US
dc.contributor.authorRatana Chawanasuntorapojen_US
dc.contributor.authorAnirut Pattaragarnen_US
dc.contributor.authorPaisal Parichatikanonden_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-08-24T02:00:20Z
dc.date.available2018-08-24T02:00:20Z
dc.date.issued2007-10-01en_US
dc.description.abstractAim: To determine the prevalence of antiphospholipid syndrome nephropathy (APSN) in Thai systemic lupus erythematosus (SLE) patients who underwent renal biopsy and to compare the relationship of renal histopathology and other significant clinical parameters between SLE patients with and without APSN. Methods: A retrospective analysis was undertaken in systemic lupus erythematosus patients (n = 150, 44 <15 years old, 106 ≥15 years old) who underwent renal biopsy. The specimens were evaluated for histological features of APSN and other significant clinical parameters. The result of antiphospholipid antibodies, clinical course, and renal function from chart review were analysed. Results: The prevalence of APSN in systemic lupus erythematosus patients who underwent renal biopsies was 34% (16% in <15-year-old group, 41.5% in ≥15-year-old group). APSN was associated with more severe hypertension (P = 0.002 for systolic and P = 0.004 for diastolic blood pressure), acute renal failure (P = 0.003), persistent heavy proteinuria (P < 0.001 for 4+ proteinuria), severe lupus nephritis (class III and IV, P = 0.014, high activity and chronicity indices, P < 0.001) and a tendency to progress to end-stage renal disease. Conclusion: Systemic lupus erythematosus patients who underwent renal biopsies in our institute showed a prevalence of APSN comparable to those in western countries. The presence of APSN was significantly higher in the adult than in the paediatric population. Its association with poor prognostic indicators suggests poor renal outcome. Clinicians should be aware of this condition in order to give proper care to systemic lupus erythematosus patients. © 2007 The Authors.en_US
dc.identifier.citationNephrology. Vol.12, No.5 (2007), 474-480en_US
dc.identifier.doi10.1111/j.1440-1797.2007.00792.xen_US
dc.identifier.issn14401797en_US
dc.identifier.issn13205358en_US
dc.identifier.other2-s2.0-34548416651en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/24725
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34548416651&origin=inwarden_US
dc.subjectMedicineen_US
dc.titlePrevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsiesen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34548416651&origin=inwarden_US

Files

Collections